- Corporate Officers - F
- Fonseca Lidia
Insider Trading History of Fonseca Lidia
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fonseca Lidia since 2017.
This trader's CIK number is 1454944.
At the time of last reporting, Fonseca Lidia was the Executive Vice President of Pfizer Inc. (stock ticker symbol PFE).
Also see all insider trading activities at Pfizer Inc.
Note that in the past
Fonseca Lidia also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pfizer Inc (PFE) by Fonseca Lidia
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | PFE | 0 | $0 | 0 | $0 | 56,888 | $1,923,952 |
| 2025 | PFE | 0 | $0 | 0 | $0 | 145,258 | $4,548,026 |
Yearly summary of insider trading at Tegna Inc (TGNA) by Fonseca Lidia
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | TGNA | 0 | $0 | 0 | $0 | 6,039 | $0 |
| 2019 | TGNA | 0 | $0 | 0 | $0 | 11,668 | $0 |
| 2018 | TGNA | 0 | $0 | 0 | $0 | 8,095 | $0 |
| 2017 | TGNA | 0 | $0 | 0 | $0 | 5,606 | $0 |
Insider trading activities at 2 companies by Fonseca Lidia:
1. Pfizer Inc (PFE)
2. Tegna Inc (TGNA)
Table 1. Insider trading of Pfizer Inc (PFE) by Fonseca Lidia
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-02-25 | PFE | Option Ex | 56,888 | 33.82 | 1,923,952 |
| 2025-02-27 | PFE | Option Ex | 72,629 | 31.31 | 2,274,013 |
| 2025-02-27 | PFE | Option Ex | 72,629 | 31.31 | 2,274,013 |
Table 2. Insider trading of Tegna Inc (TGNA) by Fonseca Lidia
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-05-01 | TGNA | Option Ex | 6,039 | .00 | 0 |
| 2019-05-01 | TGNA | Option Ex | 11,668 | .00 | 0 |
| 2018-05-01 | TGNA | Option Ex | 8,095 | .00 | 0 |
| 2017-05-01 | TGNA | Option Ex | 5,606 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Fonseca Lidia
(Executive Vice President of Pfizer Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.